CA2341304A1 - Compositions and methods for the treatment of tumors - Google Patents

Compositions and methods for the treatment of tumors Download PDF

Info

Publication number
CA2341304A1
CA2341304A1 CA002341304A CA2341304A CA2341304A1 CA 2341304 A1 CA2341304 A1 CA 2341304A1 CA 002341304 A CA002341304 A CA 002341304A CA 2341304 A CA2341304 A CA 2341304A CA 2341304 A1 CA2341304 A1 CA 2341304A1
Authority
CA
Canada
Prior art keywords
acid sequence
polypeptide
antibody
amino acid
sequence identity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002341304A
Other languages
English (en)
French (fr)
Inventor
Audrey Goddard
Austin L. Gurney
Kenneth J. Hillan
Margaret Ann Roy
William I. Wood
David Botstein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1998/018824 external-priority patent/WO1999014327A2/en
Application filed by Individual filed Critical Individual
Publication of CA2341304A1 publication Critical patent/CA2341304A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA002341304A 1998-09-10 1999-09-08 Compositions and methods for the treatment of tumors Abandoned CA2341304A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US9980398P 1998-09-10 1998-09-10
USPCT/US98/18824 1998-09-10
PCT/US1998/018824 WO1999014327A2 (en) 1997-09-17 1998-09-10 Genes amplified in tumours, antibodies against the proteins coded thereby, and their use in diagnosis and treatment of cancer
US60/099,803 1998-09-10
PCT/US1999/020594 WO2000015666A2 (en) 1998-09-10 1999-09-08 Compositions and methods for the treatment of tumors

Publications (1)

Publication Number Publication Date
CA2341304A1 true CA2341304A1 (en) 2000-03-23

Family

ID=22276704

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002341304A Abandoned CA2341304A1 (en) 1998-09-10 1999-09-08 Compositions and methods for the treatment of tumors

Country Status (8)

Country Link
EP (1) EP1109833A2 (ko)
JP (1) JP2003524380A (ko)
KR (1) KR20010103576A (ko)
AU (1) AU5816799A (ko)
CA (1) CA2341304A1 (ko)
IL (1) IL141426A0 (ko)
MX (1) MXPA01002545A (ko)
WO (1) WO2000015666A2 (ko)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001005836A1 (en) * 1999-07-20 2001-01-25 Genentech, Inc. Polypeptidic compositions and methods for the treatment of tumors
US20030049676A1 (en) 1997-09-17 2003-03-13 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US7169906B2 (en) 1997-09-17 2007-01-30 Genentech, Inc. PRO211 polypeptides
US6974689B1 (en) 1997-09-18 2005-12-13 Genentech, Inc. Nucleic acid encoding PRO211 polypeptides
EP1205550B1 (en) * 1997-09-18 2005-03-16 Genentech, Inc. Polypeptides and nucleic acids encoding the same
DK1032668T3 (da) * 1997-11-25 2008-09-29 Genentech Inc Fibroblast vækstfaktor 19
DK1185648T3 (da) * 1999-06-02 2007-07-30 Genentech Inc Fremgangsmåder og sammensætninger til inhibition af neoplastisk cellevækst
WO2001025427A1 (fr) * 1999-10-01 2001-04-12 Kyowa Hakko Kogyo Co., Ltd. Adn reagissant a la contrainte de cisaillement
DK2000545T3 (da) 2001-06-20 2011-11-28 Genentech Inc Sammensætninger og fremgangsmåder til diagnose og behandling af lunge-tumor
US20050272120A1 (en) 2001-06-20 2005-12-08 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
AU2003230874A1 (en) * 2002-04-16 2003-11-03 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
JP2005528905A (ja) 2002-06-07 2005-09-29 ジェネンテック・インコーポレーテッド 腫瘍の診断と治療のための組成物と方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999014327A2 (en) * 1997-09-17 1999-03-25 Genentech, Inc. Genes amplified in tumours, antibodies against the proteins coded thereby, and their use in diagnosis and treatment of cancer
WO1997025349A1 (en) * 1996-01-04 1997-07-17 Human Genome Sciences, Inc. Transforming growth factor alpha hiii
KR100502596B1 (ko) * 1997-09-17 2005-07-22 제넨테크, 인크. 분비 폴리펩티드와 막횡단 폴리펩티드 및 이들을 코딩하는핵산

Also Published As

Publication number Publication date
AU5816799A (en) 2000-04-03
MXPA01002545A (es) 2005-08-16
WO2000015666A2 (en) 2000-03-23
JP2003524380A (ja) 2003-08-19
WO2000015666A3 (en) 2000-11-23
KR20010103576A (ko) 2001-11-23
IL141426A0 (en) 2002-03-10
EP1109833A2 (en) 2001-06-27

Similar Documents

Publication Publication Date Title
EP1626058B1 (en) Compositions and methods for the diagnosis of tumour
US20080175842A1 (en) Compositions and methods for treatment
US20050176104A1 (en) Compositions and methods for the treatment of tumor
EP1683811B1 (en) Methods for the diagnosis of tumors
WO1999014327A2 (en) Genes amplified in tumours, antibodies against the proteins coded thereby, and their use in diagnosis and treatment of cancer
CA2341304A1 (en) Compositions and methods for the treatment of tumors
AU2192800A (en) Compositions and methods for the treatment of tumor
US6472585B1 (en) Cardiotrophin-1 defective mouse
AU776063C (en) Compositions and methods for the treatment of tumor
US7258983B2 (en) Cardiotrophin-1 compositions and methods for the treatment of tumor

Legal Events

Date Code Title Description
FZDE Discontinued